Adaptive Biotechnologies Launches $250M Convertible Senior Notes Offering Due 2031 To Repay OrbiMed Debt, Fund Share Repurchases, And Support Growth Initiatives

뉴스 본문을 불러오고 있어요.

Adaptive Biotechnologies Launches $250M Convertible Senior Notes Offering Due 2031 To Repay OrbiMed Debt, Fund Share Repurchases, And Support Growth Initiatives | 웨이프 WAPE

Adaptive Biotechnologies Launches $250M Convertible Senior Notes Offering Due 2031 To Repay OrbiMed Debt, Fund Share Repurchases, And Support Growth Initiatives

기사 요약

관련 종목

댓글 —